CORTEXYME Trademark

Trademark Overview


On Friday, June 28, 2019, a trademark application was filed for CORTEXYME with the United States Patent and Trademark Office. The USPTO has given the CORTEXYME trademark a serial number of 88493638. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 30, 2023. This trademark is owned by Cortexyme, Inc.. The CORTEXYME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious diseases, autoimmune diseases, inflammatory diseases, genetic diseases, diabetes, cardiovascular diseases, cancers, and other types of diseases and disorders; biological preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious diseases, autoimmune diseases, inflammatory diseases, genetic diseases, diabetes, cardiovascular diseases, cancers, and other types of diseases and disorders; medicinal preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious diseases, autoimmune diseases, inflammatory diseases, genetic diseases, diabetes, cardiovascular diseases, cancers, and other types of diseases and disorders
cortexyme

General Information


Serial Number88493638
Word MarkCORTEXYME
Filing DateFriday, June 28, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 30, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 29, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious diseases, autoimmune diseases, inflammatory diseases, genetic diseases, diabetes, cardiovascular diseases, cancers, and other types of diseases and disorders; biological preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious diseases, autoimmune diseases, inflammatory diseases, genetic diseases, diabetes, cardiovascular diseases, cancers, and other types of diseases and disorders; medicinal preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious diseases, autoimmune diseases, inflammatory diseases, genetic diseases, diabetes, cardiovascular diseases, cancers, and other types of diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 9, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQUINCE THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080

Party NameCortexyme, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameCortexyme, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Monday, January 30, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 30, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 26, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, June 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 21, 2022SOU EXTENSION 5 GRANTED
Friday, June 10, 2022SOU EXTENSION 5 FILED
Tuesday, June 21, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 10, 2022TEAS EXTENSION RECEIVED
Tuesday, December 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, December 12, 2021SOU EXTENSION 4 GRANTED
Sunday, December 12, 2021SOU EXTENSION 4 FILED
Sunday, December 12, 2021TEAS EXTENSION RECEIVED
Friday, June 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 16, 2021SOU EXTENSION 3 GRANTED
Wednesday, June 16, 2021SOU EXTENSION 3 FILED
Wednesday, June 16, 2021TEAS EXTENSION RECEIVED
Tuesday, December 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 18, 2020SOU EXTENSION 2 GRANTED
Friday, December 18, 2020SOU EXTENSION 2 FILED
Friday, December 18, 2020TEAS EXTENSION RECEIVED
Wednesday, December 9, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 9, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 9, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 9, 2020SOU EXTENSION 1 GRANTED
Tuesday, June 9, 2020SOU EXTENSION 1 FILED
Tuesday, June 9, 2020TEAS EXTENSION RECEIVED
Tuesday, March 10, 2020ASSIGNED TO EXAMINER
Tuesday, December 24, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 29, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 29, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 9, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 18, 2019ASSIGNED TO EXAMINER
Tuesday, July 9, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 2, 2019NEW APPLICATION ENTERED